Procter & Gamble Health Ltd Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Cr

Standalone Quarterly Results

Mar'26

Dec'25

Sep'25

Jun'25

Mar'25

Dec'24

Sep'24

Quarterly Analysis Highlights - YoY

Net Sales

YoY Growth in quarter ended Mar 2026 is 19.12% vs 23.17% in Mar 2025

Standalone Net Profit

YoY Growth in quarter ended Mar 2026 is 54.63% vs 31.40% in Mar 2025

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Mar 2026 is 67.56% vs 19.99% in Mar 2025

Interest

YoY Growth in quarter ended Mar 2026 is 61.54% vs -13.33% in Mar 2025

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025

Compare Quarterly Results Of P & G Health Ltd With

Select Peers

Figures in Cr

Standalone Quarterly Results

Change(INR)

Change(%)

Net Sales

370.45

229.20

141.25

61.63%

Other Operating Income

0.00

Total Operating income

370.45

229.20

141.25

61.63%

Raw Material Cost

85.19

40.20

44.99

111.92%

Purchase of Finished goods

22.31

18.10

4.21

23.26%

(Increase) / Decrease In Stocks

-14.63

-2.10

-12.53

-596.67%

Employee Cost

50.86

33.10

17.76

53.66%

Power Cost

0.00

Manufacturing Expenses

0.00

Selling and Distribution Expenses

0.00

Other Expenses

91.13

-89.30

180.43

202.05%

Total Expenditure (Excl Depreciation)

234.86

0.00

234.86

Operating Profit (PBDIT) excl Other Income

135.59

229.20

-93.61

-40.84%

Other Income

4.00

0.00

4.00

Operating Profit (PBDIT)

139.59

0.00

139.59

Interest

0.21

0.50

-0.29

-58.00%

Exceptional Items

0.00

Gross Profit (PBDT)

139.38

0.00

139.38

Depreciation

6.17

3.20

2.97

92.81%

Profit Before Tax

133.21

0.00

133.21

Tax

38.61

0.00

38.61

Provisions and contingencies

0.00

Profit After Tax

94.60

0.00

94.60

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

94.60

67.80

26.80

39.53%

Equity Capital

16.60

23.00

-6.40

-27.83%

Face Value

10.00

0.00

Reserves

0.00

Earnings per share (EPS)

56.99

29.48

27.51

93.32%

Diluted Earnings per share

56.99

29.44

27.55

93.58%

Operating Profit Margin (Excl OI)

36.60%

0.00%

0.00

36.60%

Gross Profit Margin

37.62%

0.00%

0.00

37.62%

PAT Margin

25.54%

0.00%

0.00

25.54%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Quarterly - Net Sales

Net Sales 370.45 Cr

in Mar 2026

Figures in Cr

QoQ Growth in quarter ended Mar 2026 is -0.91% vs 15.06% in Dec 2025

YoY Growth in quarter ended Mar 2026 is 19.12% vs 23.17% in Mar 2025

Quarterly - Standalone Net Profit

Standalone Net Profit 94.60 Cr

in Mar 2026

Figures in Cr

QoQ Growth in quarter ended Mar 2026 is 21.92% vs -12.37% in Dec 2025

YoY Growth in quarter ended Mar 2026 is 54.63% vs 31.40% in Mar 2025

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 135.59 Cr

in Mar 2026

Figures in Cr

QoQ Growth in quarter ended Mar 2026 is 22.75% vs -8.16% in Dec 2025

YoY Growth in quarter ended Mar 2026 is 67.56% vs 19.99% in Mar 2025

Quarterly - Interest

Interest 0.21 Cr

in Mar 2026

Figures in Cr

QoQ Growth in quarter ended Mar 2026 is 110.00% vs -16.67% in Dec 2025

YoY Growth in quarter ended Mar 2026 is 61.54% vs -13.33% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 36.60%

in Mar 2026

Figures in %

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025